Canada and U.S. Point Of Care Testing Market to 2032
Overview
The Canada and U.S. Point Of Care Testing Market is expected to reach a 31.72 USD Billion by 2032 and is projected to grow at a CAGR of 9.62% from 2025 to 2032.
Revenue, 2024 (USD Billion)
15.25
Forecast, 2032 (USD Billion)
31.72
CAGR, 2024 - 2032
9.62%
Report Coverage
North America
Canada and U.S. Point Of Care Testing Market 2018-2032 USD Billion
Canada and U.S. Point Of Care Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 15.25 USD Billion
- Projected Market Size (2032): 31.72 USD Billion
- CAGR (2025-2032): 9.62%
Key Findings of Canada and U.S. Point Of Care Testing Market
- The Canada and U.S. Point Of Care Testing Market was valued at 15.25 USD Billion in 2024.
- The Canada and U.S. Point Of Care Testing Market is likely to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Laboratory based Point-of-Care-Testing (POCT) in Testing Location Segment accounted for the largest share of the market with a revenue of 9.18 USD Billion
- The fastest growing segment Online Sales in Distribution Channel Segment grew Fastest with a CAGR of 10.21% during the forecast period from 2024 to 2032.
Canada and U.S. Point Of Care Testing Market Scope
Canada and U.S. Point Of Care Testing Market Segmentation & Scope
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
Method/Technology
- Others
- Microfluidics / Lab-on-a-Chip
- LAMP (Loop-Mediated Isothermal Amplification)
- NAAT (Nucleic Acid Amplification Tests)
Panel Type
- Triplex Assay
- Duplex Assay
- Multiplex Panel (Syndromic Testing)
- Simplex Assay
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Testing Location
- At-Home Point-of-Care-Testing (POCT)
- Laboratory based Point-of-Care-Testing (POCT)
Product/Disease
- Blood Yeast Infections (Fungal BSI)
- Others
- Bloodstream Infections (BSI)
- Hepatitis
- Sexually Transmitted Disease (STD)
- Gastroenteric Infections
- Respiratory Infections
Canada and U.S. Point Of Care Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 15.25 USD Billion |
| Market Value in 2032 | 31.72 USD Billion |
| CAGR (2025-2032) | 9.62% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Method/Technology,Panel Type,End User,Testing Location,Product/Disease |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 15.25 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 13,498.18 USD Million in 2024.
Segments and Scope
-
Canada and U.S. Point Of Care Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 6.74 USD Billion in the year 2024.
- Online Sales is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.30 % in forecast period 2025-2032.
-
Canada and U.S. Point Of Care Testing Market to 2032, By Method/Technology
- NAAT (Nucleic Acid Amplification Tests) is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 8.41 USD Billion in the year 2024.
- LAMP (Loop-Mediated Isothermal Amplification) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.88 % in forecast period 2025-2032.
-
Canada and U.S. Point Of Care Testing Market to 2032, By Panel Type
- Simplex Assay is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 8.01 USD Billion in the year 2024.
- Multiplex Panel (Syndromic Testing) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.53 % in forecast period 2025-2032.
-
Canada and U.S. Point Of Care Testing Market to 2032, By End User
- Hospitals is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 6.53 USD Billion in the year 2024.
- Home Care is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.83 % in forecast period 2025-2032.
-
Canada and U.S. Point Of Care Testing Market to 2032, By Testing Location
- Laboratory based Point-of-Care-Testing (POCT) is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 9.18 USD Billion in the year 2024.
- At-Home Point-of-Care-Testing (POCT) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.47 % in forecast period 2025-2032.
-
Canada and U.S. Point Of Care Testing Market to 2032, By Product/Disease
- Respiratory Infections is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 7.10 USD Billion in the year 2024.
- Sexually Transmitted Disease (STD) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.73 % in forecast period 2025-2032.
Canada and U.S. Point Of Care Testing Market Company Share Analysis
Canada and U.S. Point Of Care Testing Market Geographical Sales Distribution, 2018-2032 USD Billion
Canada and U.S. Point Of Care Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Distribution Channel,Method/Technology,Panel Type,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The Laboratory based Point-of-Care-Testing (POCT) segment is expected to dominate the Canada and U.S. Point Of Care Testing Market, holding a largest market share of 9.18 USD Billion in 2024
Coming Soon....
Canada and U.S. Point Of Care Testing Market Scope
Canada and U.S. Point Of Care Testing Market Segmentation & Scope
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
Method/Technology
- Others
- Microfluidics / Lab-on-a-Chip
- LAMP (Loop-Mediated Isothermal Amplification)
- NAAT (Nucleic Acid Amplification Tests)
Panel Type
- Triplex Assay
- Duplex Assay
- Multiplex Panel (Syndromic Testing)
- Simplex Assay
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Testing Location
- At-Home Point-of-Care-Testing (POCT)
- Laboratory based Point-of-Care-Testing (POCT)
Product/Disease
- Blood Yeast Infections (Fungal BSI)
- Others
- Bloodstream Infections (BSI)
- Hepatitis
- Sexually Transmitted Disease (STD)
- Gastroenteric Infections
- Respiratory Infections
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Distribution Channel,Method/Technology,Panel Type,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The estimated market value of the Canada and U.S. Point Of Care Testing Market for final year is USD 31.72 (USD Billion).
Canada and U.S. Point Of Care Testing Market Company Profiling
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Distribution Channel,Method/Technology,Panel Type,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The estimated market value of the Canada and U.S. Point Of Care Testing Market for final year is USD 31.72 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.